Treatment Access, Health Economics, and the Wave of a Magic Wand

by David J. Stewart, John-Peter Bradford, Gerald Batist
Published 2022-02-01

Optimal frequency of scans for patients on cancer therapies: A population kinetics assessment

by David J. Stewart, David B. Macdonald, Arif A. Awan, Kednapa Thavorn
Published 2019-11-01

Population Survival Kinetics Derived from Clinical Trials of Potentially Curable Lung Cancers

by David J. Stewart, Katherine Cole, Dominick Bosse, Stephanie Brule, Dean Fergusson, Tim Ramsay
Published 2024-03-01

Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials

by Eliya Farah, Matthew Kenney, Anris Kica, Paul Haddad, David J. Stewart, John-Peter Bradford
Published 2023-09-01

Access Denied? The Unintended Consequences of Pending Drug Pricing Rules

by Alan Kaplan, David J. Stewart, Gerald Batist, Silvana Spadafora, Sandeep Sehdev, Shaun G. Goodman
Published 2022-04-01

Determinants of the Cancer Drug Funding Process in Canada

by Joanna Gotfrit, Ashley Jackson, John J. W. Shin, David J. Stewart, Ranjeeta Mallick, Paul Wheatley-Price
Published 2022-03-01

Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data

by Ali Karimnezhad, Gareth A. Palidwor, Kednapa Thavorn, David J. Stewart, Pearl A. Campbell, Bryan Lo, Theodore J. Perkins
Published 2020-10-01

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells

by Jair Bar, Mohamed S. Hasim, Tabassom Baghai, Nima Niknejad, Theodore J. Perkins, David J. Stewart, Harmanjatinder S. Sekhon, Patrick J. Villeneuve, Jim Dimitroulakos
Published 2016-09-01

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

by Srishti Kumar, Alexandria Bennett, Pearl A. Campbell, Gareth Palidwor, Bryan Lo, Theodore J. Perkins, Surapon Nochaiwong, Harmanjatinder S. Sekhon, David J. Stewart, Kednapa Thavorn
Published 2022-07-01

ALK inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.

by Jesse Elliott, Zemin Bai, Shu-Ching Hsieh, Shannon E Kelly, Li Chen, Becky Skidmore, Said Yousef, Carine Zheng, David J Stewart, George A Wells
Published 2020-01-01

The importance of greater speed in drug development for advanced malignancies

by David J. Stewart, Andrew A. Stewart, Paul Wheatley‐Price, Gerald Batist, Hagop M. Kantarjian, Joan Schiller, Mark Clemons, John‐Peter Bradford, Laurel Gillespie, Razelle Kurzrock
Published 2018-05-01

The need for speed in advanced non‐small cell lung cancer: A population kinetics assessment

by David J. Stewart, Donna E. Maziak, Sara M. Moore, Stephanie Y. Brule, Marcio Gomes, Harman Sekhon, Carole Dennie, Bryan Lo, Michael Fung‐Kee‐Fung, John‐Peter Bradford, Martin Neil Reaume
Published 2021-12-01

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

by Daniel Morgensztern, Manuel Cobo Dols, Santiago Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, Jürgen R. Fischer, Oscar Juan-Vidal, David J. Stewart, Andrea Ardizzoni, Rafia Bhore, Marianne Wolfsteiner, Martin Reck, Denis Talbot, Ramaswamy Govindan, Teng Jin Ong
Published 2021-02-01

Cancer Clinic Redesign: Opportunities for Resource Optimization

by Michael Fung-Kee-Fung, Rachel S. Ozer, Bill Davies, Stephanie Pick, Kate Duke, David J. Stewart, M. Neil Reaume, Marcus Ward, Katelyn Balchin, Robert M. MacRae, Shannon Nelson, Julie Renaud, Dennis Garvin, Suzanne Madore, Jason R. Pantarotto
Published 2022-05-01

New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices

by David J. Stewart, John-Peter Bradford, Sandeep Sehdev, Tim Ramsay, Vishal Navani, Nigel S. B. Rawson, Di Maria Jiang, Joanna Gotfrit, Paul Wheatley-Price, Geoffrey Liu, Alan Kaplan, Silvana Spadafora, Shaun G. Goodman, Rebecca A. C. Auer, Gerald Batist
Published 2024-04-01

Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.

by Michelle A T Hildebrandt, Ritsuko Komaki, Zhongxing Liao, Jian Gu, Joe Y Chang, Yuanqing Ye, Charles Lu, David J Stewart, John D Minna, Jack A Roth, Scott M Lippman, James D Cox, Waun Ki Hong, Margaret R Spitz, Xifeng Wu
Published 2010-08-01

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.

by Charles Lu, David J Stewart, J Jack Lee, Lin Ji, Rajagopal Ramesh, Gitanjali Jayachandran, Maria I Nunez, Ignacio I Wistuba, Jeremy J Erasmus, Marshall E Hicks, Elizabeth A Grimm, James M Reuben, Veerabhadran Baladandayuthapani, Nancy S Templeton, John D McMannis, Jack A Roth
Published 2012-01-01

Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement

by Sandeep R. Sehdev, Nigel S. B. Rawson, Olexiy I. Aseyev, Catriona J. Buick, Marcus O. Butler, Scott Edwards, Sharlene Gill, Joanna M. Gotfrit, Cyrus C. Hsia, Rosalyn A. Juergens, Mita Manna, Joy S. McCarthy, Som D. Mukherjee, Stephanie L. Snow, Silvana Spadafora, David J. Stewart, Jason R. Wentzell, Ralph P. W. Wong, Pawel G. Zalewski
Published 2024-03-01

Dimension yields from short logs of low-quality hardwood trees /

by Rosen, Howard N., Polak, David J., Stewart, Harold A., North Central Forest Experiment Station (Saint Paul, Minn.)
Published 1980

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro

by Al-Lamki, Rafia S., Hudson, Nicholas J., Bradley, John R., Warren, Anne Y., Eisen, Tim, Welsh, Sarah J., Riddick, Antony C. P., O’Mahony, Fiach C., Turnbull, Arran, Powles, Thomas, SCOTRRCC Collaborative, SCOTRRCC Collaborative, Reverter, Antonio, Harrison, David J., Stewart, Grant D.
Published 2020